Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000221369> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2000221369 endingPage "369" @default.
- W2000221369 startingPage "366" @default.
- W2000221369 abstract "Gefitinib (ZD1839, Iressa ), a selective inhibitor of the epidermal growth factor receptor-tyrosine kinase, is currently in clinical trials to treat a variety of solid tumors. Similar side effects were seen in numerous clinical trials of gefitinib, including recent phase II trials (Iressa Dose Evaluation in Advanced Lung Cancer [IDEAL]-1 and IDEAL-2) in patients with advanced, previously treated non-small-cell lung cancer (NSCLC). The most frequent drug-related adverse effects reported in these trials were diarrhea, dry skin, acneiform rash, and nausea and vomiting. Recently, IDEAL-2 investigators and oncology nurses participated in a panel discussion on the management of dermatologic adverse effects associated with gefitinib treatment. These dermatologic effects were related to the mechanism of action of gefitinib and were not caused by a drug-related allergic reaction. In IDEAL-2, investigators managed the symptoms of dry skin and rash with a variety of treatments, including topical clindamycin, antibiotics, and corticosteroids. Most patients had a high level of tolerance for the dermatologic effects associated with gefitinib, which were milder than toxicities associated with chemotherapy. The severity of skin effects cycled over time during treatment but typically subsided after several weeks of gefitinib treatment. In general, dermatologic effects of gefitinib were easily managed, reversible, and well tolerated by these patients with advanced NSCLC." @default.
- W2000221369 created "2016-06-24" @default.
- W2000221369 creator A5008593691 @default.
- W2000221369 creator A5026987586 @default.
- W2000221369 creator A5027179586 @default.
- W2000221369 creator A5064953304 @default.
- W2000221369 date "2003-05-01" @default.
- W2000221369 modified "2023-09-25" @default.
- W2000221369 title "Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and Management" @default.
- W2000221369 cites W1896634820 @default.
- W2000221369 cites W2002859032 @default.
- W2000221369 cites W2010174111 @default.
- W2000221369 cites W2049399926 @default.
- W2000221369 cites W2055901820 @default.
- W2000221369 cites W2055903396 @default.
- W2000221369 cites W2058992264 @default.
- W2000221369 cites W2064047613 @default.
- W2000221369 cites W2079286299 @default.
- W2000221369 cites W2104431314 @default.
- W2000221369 cites W2114291028 @default.
- W2000221369 cites W2135836172 @default.
- W2000221369 cites W2142661339 @default.
- W2000221369 cites W2167531081 @default.
- W2000221369 cites W2169332099 @default.
- W2000221369 doi "https://doi.org/10.3816/clc.2003.n.016" @default.
- W2000221369 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14599302" @default.
- W2000221369 hasPublicationYear "2003" @default.
- W2000221369 type Work @default.
- W2000221369 sameAs 2000221369 @default.
- W2000221369 citedByCount "103" @default.
- W2000221369 countsByYear W20002213692012 @default.
- W2000221369 countsByYear W20002213692013 @default.
- W2000221369 countsByYear W20002213692014 @default.
- W2000221369 countsByYear W20002213692015 @default.
- W2000221369 countsByYear W20002213692016 @default.
- W2000221369 countsByYear W20002213692017 @default.
- W2000221369 countsByYear W20002213692019 @default.
- W2000221369 countsByYear W20002213692020 @default.
- W2000221369 countsByYear W20002213692021 @default.
- W2000221369 countsByYear W20002213692022 @default.
- W2000221369 countsByYear W20002213692023 @default.
- W2000221369 crossrefType "journal-article" @default.
- W2000221369 hasAuthorship W2000221369A5008593691 @default.
- W2000221369 hasAuthorship W2000221369A5026987586 @default.
- W2000221369 hasAuthorship W2000221369A5027179586 @default.
- W2000221369 hasAuthorship W2000221369A5064953304 @default.
- W2000221369 hasConcept C121608353 @default.
- W2000221369 hasConcept C126322002 @default.
- W2000221369 hasConcept C143998085 @default.
- W2000221369 hasConcept C16005928 @default.
- W2000221369 hasConcept C197934379 @default.
- W2000221369 hasConcept C2776256026 @default.
- W2000221369 hasConcept C2778570526 @default.
- W2000221369 hasConcept C2779438470 @default.
- W2000221369 hasConcept C2780580887 @default.
- W2000221369 hasConcept C535046627 @default.
- W2000221369 hasConcept C71924100 @default.
- W2000221369 hasConceptScore W2000221369C121608353 @default.
- W2000221369 hasConceptScore W2000221369C126322002 @default.
- W2000221369 hasConceptScore W2000221369C143998085 @default.
- W2000221369 hasConceptScore W2000221369C16005928 @default.
- W2000221369 hasConceptScore W2000221369C197934379 @default.
- W2000221369 hasConceptScore W2000221369C2776256026 @default.
- W2000221369 hasConceptScore W2000221369C2778570526 @default.
- W2000221369 hasConceptScore W2000221369C2779438470 @default.
- W2000221369 hasConceptScore W2000221369C2780580887 @default.
- W2000221369 hasConceptScore W2000221369C535046627 @default.
- W2000221369 hasConceptScore W2000221369C71924100 @default.
- W2000221369 hasIssue "6" @default.
- W2000221369 hasLocation W20002213691 @default.
- W2000221369 hasLocation W20002213692 @default.
- W2000221369 hasOpenAccess W2000221369 @default.
- W2000221369 hasPrimaryLocation W20002213691 @default.
- W2000221369 hasRelatedWork W1618072806 @default.
- W2000221369 hasRelatedWork W1824070893 @default.
- W2000221369 hasRelatedWork W1969875143 @default.
- W2000221369 hasRelatedWork W2015910003 @default.
- W2000221369 hasRelatedWork W2017389411 @default.
- W2000221369 hasRelatedWork W2027737109 @default.
- W2000221369 hasRelatedWork W2186047679 @default.
- W2000221369 hasRelatedWork W2261901203 @default.
- W2000221369 hasRelatedWork W2978946191 @default.
- W2000221369 hasRelatedWork W2103674109 @default.
- W2000221369 hasVolume "4" @default.
- W2000221369 isParatext "false" @default.
- W2000221369 isRetracted "false" @default.
- W2000221369 magId "2000221369" @default.
- W2000221369 workType "article" @default.